These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 18578432)

  • 1. [Empirical antibiotic therapy for febrile neutropenia].
    Kridel R; Van Delden C; Calandra T; Marchetti O
    Rev Med Suisse; 2008 Apr; 4(152):914, 916-9. PubMed ID: 18578432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients.
    Glasmacher A; von Lilienfeld-Toal M; Schulte S; Hahn C; Schmidt-Wolf IG; Prentice A
    Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():17-23. PubMed ID: 16138815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia.
    Bal AM; Gould IM
    Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Standards, Options, and Recommendations for the management of brief neutropenias. Fedération Nationale des Centres de Lutte Contre le Cancer].
    Biron P; Fuhrmann C; Escande MC; Blanc-Vincent MP; Crokaert F; Béal J; Bussy V; Lesimple T; Pottecher B; Raveneau J; Senet JM; Viot M
    Bull Cancer; 1998 Aug; 85(8):695-711. PubMed ID: 9754078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
    Girmenia C; Russo E; Carmosino I; Breccia M; Dragoni F; Latagliata R; Mecarocci S; Morano SG; Stefanizzi C; Alimena G
    Ann Hematol; 2007 Apr; 86(4):263-70. PubMed ID: 17225113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
    J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cherif H; Johansson E; Björkholm M; Kalin M
    Haematologica; 2006 Feb; 91(2):215-22. PubMed ID: 16461306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febrile neutropenia in haematological malignancies.
    Sharma A; Lokeshwar N
    J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.
    Bennett JE; Powers J; Walsh T; Viscoli C; de Pauw B; Dismukes W; Galgiani J; Glauser M; Herbrecht R; Kauffman C; Lee J; Pappas P; Rex J; Verweij P
    Clin Infect Dis; 2003 Apr; 36(Suppl 3):S117-22. PubMed ID: 12679895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical antibiotics for febrile neutropenic cancer patients.
    Hathorn JW
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S43-51. PubMed ID: 2693109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Empirical antibiotic therapy in febrile neutropenic patients with acute leukemia].
    Yabe H; Nakamura F; Ishikawa T; Nagai K; Nakayama S
    Rinsho Ketsueki; 1989 May; 30(5):644-9. PubMed ID: 2795878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.
    Sipsas NV; Bodey GP; Kontoyiannis DP
    Cancer; 2005 Mar; 103(6):1103-13. PubMed ID: 15666328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of fever in neutropenic patients with different risks of complications.
    Klastersky J
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of febrile neutropenic patients].
    Takata T; Tamura K
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):13-8. PubMed ID: 16410691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Febrile neutropenia].
    Bally F; Marchetti O; Cometta A
    Rev Prat; 2003 Dec; 53(19):2101-7. PubMed ID: 15008466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic therapy in leukopenia].
    Böhme A; Shah PM; Stille W; Hoelzer D
    Praxis (Bern 1994); 1998 Sep; 87(36):1120-5. PubMed ID: 9782739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.